Latest Biotech News

UC San Diego researchers described CANDiT, a machine‑learning systems biology framework that identifies targets to reprogram cancer stem cells toward differentiation and cell death. Applied to...

The Jackson Laboratory completed its acquisition of the New York Stem Cell Foundation, combining JAX’s genetics infrastructure with NYSCF’s human stem cell platforms. The transaction creates an...

Chugai Pharmaceutical signed a global collaboration and license with Rani Therapeutics to develop an oral product that pairs Rani’s Ranipill robotic delivery platform with a Chugai rare‑disease...

New FDA hiring data show the agency’s drug and biologics centers recorded nearly 1,000 net departures in the last quarter of fiscal 2025, marking a historic outflow that offsets hundreds of hires....

Researchers at the Allen Institute and UCSF developed CellTransformer, an AI neural network that classified 3.9 million mouse brain cells across >5,000 neuron types to produce a data‑driven brain...

Grail said Monday it has agreed a private placement expected to raise roughly $325 million to fund commercial expansion and reimbursement efforts for its Galleri circulating tumor DNA (ctDNA)...

Exelixis presented detailed STELLAR-303 Phase 3 data showing its oral TKI zanzalintinib plus Roche’s Tecentriq reduced the risk of death by about 20% versus Stivarga in previously treated...

ESMO presentations sharpened a head‑to‑head narrative between AstraZeneca/Daiichi Sankyo’s Datroway and Gilead’s Trodelvy in triple‑negative breast cancer and other difficult indications. At the...

Replimune said it has resubmitted data for RP1, its oncolytic therapy for melanoma, prompting the FDA to grant a second review with a new decision date set for April 10. The company’s resubmission...

Anthropic launched 'Claude for Life Sciences,' a large‑language model (LLM) tailored to research workflows, and announced collaborations with 10x Genomics and Benchling to integrate the model into...

Roche presented Phase 3 data showing ctDNA‑guided adjuvant Tecentriq prolonged survival for a subset of bladder cancer patients identified as high risk by a circulating tumor DNA test. The data,...

Researchers reported at ESMO and in accompanying analyses that mRNA COVID‑19 vaccines can enhance the efficacy of immune checkpoint inhibitors. MD Anderson presented retrospective data showing...

Chugai Pharmaceutical struck a global license and collaboration with Rani Therapeutics to develop an oral product combining Rani’s Ranipill robotic oral delivery technology with a Chugai...

An Alliance for Clinical Trials in Oncology study published in the Journal of Clinical Oncology reported high remission rates in older adults with B‑cell acute lymphoblastic leukemia using...

New agency hiring data show nearly 1,000 net departures from the FDA’s drug and biologics centers in the last quarter of fiscal 2025, marking an historic outflow that industry and policymakers say...

AstraZeneca and Daiichi Sankyo reported Datroway extended survival in patients with triple-negative breast cancer (TNBC) who were ineligible for immunotherapy, while Gilead’s Trodelvy continues to...

Exelixis disclosed Phase 3 results showing its oral TKI zanzalintinib, combined with Roche’s Tecentriq, reduced the risk of death by about 20% versus the standard comparator in previously treated...

Cancer early‑detection company Grail announced a securities purchase agreement expected to raise approximately $325 million in a private placement, citing new and existing institutional investors...

Genomics unveiled Mystra, an AI‑enabled human‑genetics platform designed to accelerate target discovery and clinical validation by harmonizing large GWAS and multiomic datasets. The company...

Roche presented Phase 3 data showing adjuvant Tecentriq (atezolizumab) guided by circulating tumor DNA (ctDNA) prolonged survival in a higher‑risk bladder cancer subset identified by blood...